OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia
Ross Tynan, Judith Weidenhofer, Madeleine Hinwood, et al.
Brain Behavior and Immunity (2012) Vol. 26, Iss. 3, pp. 469-479
Closed Access | Times Cited: 347

Showing 1-25 of 347 citing articles:

Depression as a Microglial Disease
Raz Yirmiya, Neta Rimmerman, R. Reshef
Trends in Neurosciences (2015) Vol. 38, Iss. 10, pp. 637-658
Closed Access | Times Cited: 768

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis
Tirzah Kreisel, Matthew G. Frank, Tamar Licht, et al.
Molecular Psychiatry (2013) Vol. 19, Iss. 6, pp. 699-709
Open Access | Times Cited: 609

The Pathogenesis of Sepsis and Potential Therapeutic Targets
Min Huang, Shaoli Cai, Jingqian Su
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5376-5376
Open Access | Times Cited: 598

Integrating neuroimmune systems in the neurobiology of depression
Eric S. Wohleb, Tina Franklin, Masaaki Iwata, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 8, pp. 497-511
Closed Access | Times Cited: 580

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Gislaine Z. Réus, Gabriel R. Fries, Laura Stertz, et al.
Neuroscience (2015) Vol. 300, pp. 141-154
Closed Access | Times Cited: 527

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Cristiano A. Köhler, Thiago Holanda Freitas, Brendon Stubbs, et al.
Molecular Neurobiology (2017)
Closed Access | Times Cited: 411

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Rudolf Uher, Katherine E. Tansey, Tracy Dew, et al.
American Journal of Psychiatry (2014) Vol. 171, Iss. 12, pp. 1278-1286
Closed Access | Times Cited: 376

Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience
Caroline Ménard, Madeline L. Pfau, Georgia E. Hodes, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 62-80
Open Access | Times Cited: 328

Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
Jia Jia Liu, Ya Bin Wei, Rebecca Strawbridge, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 2, pp. 339-350
Closed Access | Times Cited: 328

Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer, Roos van Westrhenen, Marieke J.H. Begemann, et al.
Schizophrenia Bulletin (2013) Vol. 40, Iss. 1, pp. 181-191
Open Access | Times Cited: 318

Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function
Frederick R. Walker, Michael Nilsson, Kim Jones
Current Drug Targets (2013) Vol. 14, Iss. 11, pp. 1262-1276
Open Access | Times Cited: 295

A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
Nicole L. Baganz, Randy Blakely
ACS Chemical Neuroscience (2012) Vol. 4, Iss. 1, pp. 48-63
Open Access | Times Cited: 291

Microglial Dysregulation in Psychiatric Disease
Luciana Romina Frick, Kyle A. Williams, Christopher Pittenger
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-10
Open Access | Times Cited: 272

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
Sarah A. Hiles, Amanda Baker, Theo de Malmanche, et al.
Brain Behavior and Immunity (2012) Vol. 26, Iss. 7, pp. 1180-1188
Open Access | Times Cited: 257

Cardiovascular disease in autoimmune rheumatic diseases
Ivana Hollan, Pier Luigi Meroni, Joseph M. Ahearn, et al.
Autoimmunity Reviews (2013) Vol. 12, Iss. 10, pp. 1004-1015
Closed Access | Times Cited: 249

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
Oliver Howes, Robert A. McCutcheon
Translational Psychiatry (2017) Vol. 7, Iss. 2, pp. e1024-e1024
Open Access | Times Cited: 247

Switching of the Microglial Activation Phenotype Is a Possible Treatment for Depression Disorder
Lijuan Zhang, Jinqiang Zhang, Zili You
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 241

Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration
Sheela Vyas, Ana João Rodrigues, Joana Silva, et al.
Neural Plasticity (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 238

Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease
Forugh S. Dafsari, Frank Jessen
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 218

Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study
Elaine Setiawan, Sophia Attwells, Alan A. Wilson, et al.
The Lancet Psychiatry (2018) Vol. 5, Iss. 4, pp. 339-347
Closed Access | Times Cited: 216

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Heeok Hong, Byung Sun Kim, Heh‐In Im
International Neurourology Journal (2016) Vol. 20, Iss. Suppl 1, pp. S2-7
Open Access | Times Cited: 215

Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Jeffrey H. Meyer, Simon Červenka, Min-Jeong Kim, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 12, pp. 1064-1074
Open Access | Times Cited: 203

Microglia in depression: current perspectives
Xiaoning Jia, Zhihua Gao, Hailan Hu
Science China Life Sciences (2020) Vol. 64, Iss. 6, pp. 911-925
Open Access | Times Cited: 197

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 173

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
Erica M. Richards, Paolo Zanotti‐Fregonara, Masahiro Fujita, et al.
EJNMMI Research (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 166

Page 1 - Next Page

Scroll to top